Risk of cardiometabolic outcomes among women with a history of pelvic inflammatory disease: a retrospective matched cohort study from the UK

被引:1
|
作者
Okoth, Kelvin [1 ]
Thomas, G. Neil [1 ]
Nirantharakumar, Krishnarajah [1 ,2 ,3 ]
Adderley, Nicola J. [1 ]
机构
[1] Univ Birmingham, Inst Appl Hlth Res, Birmingham, England
[2] Univ Birmingham, Inst Metab & Syst Res, Birmingham, England
[3] Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab, Birmingham, England
关键词
Pelvic inflammatory disease; Cardiovascular disease; Hypertension; Type 2 diabetes mellitus; PREVALENCE; DIAGNOSES; ENGLAND; TRENDS; BIAS;
D O I
10.1186/s12905-023-02214-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
IntroductionTo describe the incidence and prevalence of pelvic inflammatory disease (PID) and to estimate the risk of cardiometabolic outcomes among women with PID compared to women without PID.MethodsA UK retrospective matched cohort study using data from The Health Improvement Network. To assess cardiometabolic risk, women (aged >= 16 years) with PID were compared to matched controls without PID. Annual prevalence and incidence of PID (1998-2017) were estimated among women aged 16-50 years using annual cross-sectional and cohort analyses, respectively. Adjusted hazard ratios (aHR) and 95% CI for cardiometabolic outcomes were estimated using Cox proportional hazards models. The primary outcome was composite cardiovascular disease (CVD) and its subtypes, including ischaemic heart disease (IHD), heart failure (HF) and cerebrovascular disease. Secondary outcomes were hypertension, and type 2 diabetes mellitus (T2DM).ResultsAmong the 715 recorded composite CVD events, the crude incidence rate per 1000 person-years was 1.5 among women with history of PID compared to 1.3 in matched controls. Compared to women without PID (N = 73,769), the aHRs for cardiometabolic outcomes among women with PID (N = 19,804) were: composite CVD 1.10 (95% CI 0.93-1.30); IHD 1.19 (95% CI 0.93-1.53); cerebrovascular disease 1.13 (95% CI 0.90-1.43); HF 0.92 (95% CI 0.62-1.35) hypertension 1.10 (95% CI 1.01-1.20); and T2DM 1.25 (95% CI 1.09-1.43). The prevalence (per 10,000 population) of PID was 396.5 in 1998 and 237 in 2017. The incidence (per 10,000 person-years) of PID was 32.4 in 1998 and 7.9 in 2017.ConclusionThere was no excess risk of composite CVD or its subtypes among women with history of PID compared to matched controls. Findings from our study suggest that history of PID was associated with an increased risk of hypertension and type 2 diabetes mellitus, two major risk factors for CVD. Additional studies are required to support these findings.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Risk of cardiometabolic outcomes among women with a history of pelvic inflammatory disease: a retrospective matched cohort study from the UK
    Kelvin Okoth
    G. Neil Thomas
    Krishnarajah Nirantharakumar
    Nicola J. Adderley
    BMC Women's Health, 23
  • [2] Risk of colorectal cancer in women with pelvic inflammatory disease: a matched cohort study
    Hsu, M-I
    Lin, H-W
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 121 (03) : 337 - 342
  • [3] Risk of cardiovascular outcomes among women with endometriosis in the United Kingdom: a retrospective matched cohort study
    Okoth, K.
    Wang, J.
    Zemedikun, D.
    Thomas, G. N.
    Nirantharakumar, K.
    Adderley, N. J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 128 (10) : 1598 - 1609
  • [4] The association between menstrual cycle characteristics and cardiometabolic outcomes in later life: a retrospective matched cohort study of 704,743 women from the UK
    Okoth, Kelvin
    Smith, William Parry
    Thomas, G. Neil
    Nirantharakumar, Krishnarajah
    Adderley, Nicola J.
    BMC MEDICINE, 2023, 21 (01)
  • [5] The association between menstrual cycle characteristics and cardiometabolic outcomes in later life: a retrospective matched cohort study of 704,743 women from the UK
    Kelvin Okoth
    William Parry Smith
    G. Neil Thomas
    Krishnarajah Nirantharakumar
    Nicola J. Adderley
    BMC Medicine, 21
  • [6] Pelvic inflammatory disease and risk of cancer: A nationwide cohort study
    Sogaard, Kirstine K.
    Leisner, Michelle Z.
    Laugesen, Kristina
    Farkas, Dora K.
    Karagas, Margaret R.
    Sorensen, Henrik T.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2020, 149 (01) : 107 - 109
  • [7] Increased risk of borderline ovarian tumors in women with a history of pelvic inflammatory disease: A nationwide population-based cohort study
    Rasmussen, Christina B.
    Jensen, Allan
    Albieri, Vanna
    Andersen, Klaus K.
    Kjaer, Susanne K.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (02) : 346 - 351
  • [8] Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study
    Shen, Cheng-Che
    Hu, Li-Yu
    Yang, Albert C.
    Chiang, Yung-Yen
    Hung, Jeng-Hsiu
    Tsai, Shih-Jen
    BMC CANCER, 2016, 16
  • [9] The Combination of Clindamycin and Gentamicin Is Adequate for Pelvic Inflammatory Disease: A Retrospective Cohort Study
    Chen, Li-Yeh
    Harnod, Tomor
    Chang, Yu-Hsun
    Chen, Hsuan
    Ding, Dah-Ching
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (18)
  • [10] Risk of psychiatric disorders following pelvic inflammatory disease: a nationwide population-based retrospective cohort study
    Shen, Cheng-Che
    Yang, Albert C.
    Hung, Jeng-Hsiu
    Hu, Li-Yu
    Chiang, Yung-Yen
    Tsai, Shih-Jen
    JOURNAL OF PSYCHOSOMATIC OBSTETRICS & GYNECOLOGY, 2016, 37 (01) : 6 - 11